Results 211 to 220 of about 2,392,188 (303)

Olfactory Dysfunction and Metabolic Syndrome Components: A Systematic Review and Meta‐Analysis

The Laryngoscope, EarlyView.
ABSTRACT Objective To elucidate the association between olfactory dysfunction (OD) and metabolic syndrome components. Data Sources PubMed (National Library of Medicine—National Institutes of Health), Scopus (Elsevier), CINAHL Complete (EBSCOhost), and the Cochrane Library (Wiley) databases were searched from inception through March 23rd, 2026.
Neeti Gandra, Kaitlyn A. Roberts, Shaun A. Nguyen, Pete Peters, Lauren A. Howser, Zachary M. Soler, Rodney J. Schlosser   +6 more
wiley   +1 more source

Triglyceride-Rich Lipoproteins and ASCVD: Evidence for Causality and Challenges in Therapeutic Translation. [PDF]

Curr Atheroscler Rep
Björnson E, Adiels M.
europepmc   +1 more source

Circulating Omega‐3 Fatty Acids and Cardiometabolic Outcomes: A Systematic Review of Publications From UK Biobank

Lipids, EarlyView.
ABSTRACT Studies have shown that omega‐3 fatty acids may protect against cardiovascular diseases (CVDs) and related metabolic conditions. UK Biobank is a large cohort study that includes data on plasma omega‐3 fatty acids at study entry and health outcomes during the follow‐up period.
Warda Tul Firdous, Philip C. Calder
wiley   +1 more source

Changes in Lipoprotein Fractions and Lipoprotein-Associated Alpha-Tocopherol After Sleeve Gastrectomy in Patients With Severe Obesity. [PDF]

Cardiol Res
Katsuyama H, Hirowatari Y, Manita D, Iwasaki T, Yoshio S, Inamine S, Hakoshima M, Kawaguchi T, Yanai H.   +8 more
europepmc   +1 more source

The Role and Assessment of Lipid Profile in Patients With a Chronic Total Coronary Occlusion

Lipids, EarlyView.
This review summarized evidence on lipid profiles in CTO patients, non‐CTO patients, and healthy individuals, and examined the reported associations between lipid parameters, collateral channel formation, and clinical outcomes. Several key findings emerged from the present study.
Karol Sadowski, Dominika Tomkiel, Roel Hoek, Ruben W. de Winter, Nick S. Nurmohamed, Bimmer E. P. M. Claessen, Niels J. Verouden, Alexander Nap, Sebastiaan A. Kleijn, Mariusz Tomaniak, Yvemarie B. O. Somsen, Paul Knaapen   +11 more
wiley   +1 more source

Lipid Immunometabolism in Autoimmune Rheumatic Diseases: Mechanistic Links Between Chronic Inflammation, Lipoprotein Dysfunction and Cardiovascular Risk. [PDF]

Biology (Basel)
Bonanni L, Ferri N.
europepmc   +1 more source

Hyperhomocysteinemia and Vitamin B Deficiency as Potential Aggravating Factors in Huntington's Disease: A Prospective Monocentric Study

Movement Disorders, EarlyView.
Abstract Background Although not confirmed, some studies have suggested that elevated homocysteine levels are common in patients with Huntington's disease (HD). Its clinical relevance remains unclear. Objectives We aimed to assess vitamin B and homocysteine levels in HD patients and explore the relationships among hyperhomocysteinemia, vitamin B ...
Salomé Puisieux, Elise Pourié, Céline Bonnet, Lucie Hopes, Solène Frismand, Myriam Bronner, Virginie Roth, Marion Wandzel, Natacha Sloboda, Laetitia Lambert, Abderrahim Oussalah, Amélia Julien, Irina Rotaru, Rosa‐Maria Guéant‐Rodriguez, Jean Louis Guéant, Carine Bossenmeyer‐Pourié, Mathilde Renaud   +16 more
wiley   +1 more source

What Are the Potential Therapeutic Benefits of Targeting Blood-Borne Lipoproteins in the Treatment of Alzheimer's Disease? [PDF]

Cells
Robert J.
europepmc   +1 more source

Impact of Dietetic Counseling Combined With Digital Tools on Obesity‐Related Indices in Greek Adults: The GATEKEEPER Study

Obesity, EarlyView.
ABSTRACT Objective This study aimed to evaluate the effectiveness of dietetic counseling with digital tools on obesity‐related and metabolic outcomes in adults aged ≥ 55 years at high risk for metabolic syndrome (MetS). Methods In this 3‐month randomized controlled trial, 984 adults aged ≥ 55 years with ≥ 1 MetS risk factor were randomized (1:1:1) to ...
Rafaela Makri, Iliana Evangelou, Eva Karaglani, Maria Vlachava, George E. Dafoulas, Ioanna Drympeta, Konstantinos Votis, Eleni I. Georga, Dimitrios I. Fotiadis, Francisco Lupiáñez‐Villanueva, Frans Folkvord, Leandro Pecchia, Giuseppe Fico, Demosthenes Panagiotakos, Odysseas Androutsos, Yannis Manios, GATEKEEPER study (Greek Use Case 1) group, Odysseas Androutsos, Maria Vlachava, Iliana Evangelou, George E. Dafoulas, Alexandra Bargiota, Alexandra Koubitski, Avgi Karaiskou, Glykeria Papagiannopoulou, Thanasis Topis, Thomas Tzekos, Nelly Mylona, Nikos Papaspanos, Yvonne Katergari, Iphigenia Chionidou, Natasha Davitidou, Vivian Katsarou, Yannis Manios, Eva Karaglani, Rafaela Makri, Ilektra Kalogerakou, Alexandros Karagiannis, Ioanna Nakaki, Elpiniki Vlachopoulou, Maria Dimopoulou, Maria Skaltsa, Ioannis Chrysou, Konstantinos Leontiou, Karamperi Katerina, Evangelia Malakou, Anastasios Papalazarou, Elisavet Parlapani, Anastasia Paschaleri, Christos Paximadas, Maria‐Sofia Pelagidou, Kyriakos Reppas, Katerina Tyrothoulaki, Konstantinos Xenos, Spyridon Zarogiannis, Konstantinos Zervos, Ilias Kalamaras, Dimitrios I. Fotiadis, Eleni I. Georga, Daphne N. Katsarou   +59 more
wiley   +1 more source

Kidney-Vascular Metabolic Crosstalk: Altered Lipoproteins in CKD. [PDF]

Circ Res
Saum KL, Pennathur S, Kanter JE.
europepmc   +1 more source